Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2011

View Archived Issues

Ortho-McNeil-Janssen discloses new gamma-secretase modulators

Tempero Pharmaceuticals presents novel histone deacetylase 9 inhibitors

Apricus seeks approval in Latin America for topical erectile dysfunction drug

New lysophospholipid S1P1 receptor agonists claimed

Stiefel submits NDA for tazarotene foam

Johns Hopkins receives NIH funding for 5-year research project

Pseudotyped VLP-based vaccines show promise against hepatitis C

Sanofi discovers novel CaMK-II subunit delta inhibitors

CR-845 advances in new phase II trial in postoperative pain

Intercept Pharmaceuticals and Servier enter diabetes collaboration

FDA approves generic levetiracetam injection

Scientists to assess biomarkers in ProTECT trial participants

Arena Pharmaceuticals and Eisai report on lorcaserin carcinogenicity study

Meridian Bioscience launches new rapid test for CDI in Europe

Quidel molecular RT-PCR assay obtains CE mark approval

U.S. Department of Defense contracts Neuralstem to develop brain tumor therapy

Helsinn Therapeutics begins ROMANA 1 and 2 trials in NSCLC-related cachexia

MMV identifies new antimalarial aminopyridine derivatives

Stellar Biotech and Sigma-Aldrich collaborate for keyhole limpet hemocyanin

NanoViricides provides pipeline update and plans first IND submission

DelMar Pharmaceuticals receives Canada Industrial Research Assistance Program funding

New radioimmunotherapy enters phase I evaluation in HER2-positive intra-abdominal cancers

Histone deacetylase 6 inhibitor reverses symptoms of Charcot-Marie-Tooth disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...